Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Dietary fiber-mediated gut modulation" is not a specific molecule, receptor, or canonical therapeutic target. Instead, it refers to the process by which dietary fibers—complex carbohydrates that are not digested in the upper gastrointestinal tract—are fermented by the gut microbiota in the colon. This fermentation produces metabolites such as short-chain fatty acids (SCFAs), including acetate, propionate, and butyrate, which play key roles in maintaining intestinal health and modulating immune responses. The type and structure of dietary fibers influence which bacterial populations thrive in the gut; for example, certain fibers promote beneficial bacteria like Bifidobacterium and Lactobacillus while reducing potentially harmful species. These changes can impact host physiology by improving barrier function, reducing inflammation, supporting metabolic health, and potentially protecting against diseases such as obesity and type 2 diabetes. However, "dietary fiber-mediated gut modulation" is a physiological process rather than a discrete molecular entity or druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary fiber-mediated gut modulation.